Muaiad Kittaneh









Related Media Materials :

Alquds Alarabi Newspaper Please Click : link
Panet Website Please Click : link

Editorial Board:

Austin Journal of Cancer and Clinical Research

Journal Reviewer:

The American Journal of Clinical Oncology (AJCO)-2012- current.The British Journal of Cancer (Nature publishing group)-2013-current


  1. Molecular  Profiling  for  Breast  Cancer:  A  Comprehensive  Review.  Biomarkers  in  cancer; Muaiad Kittaneh, Alberto  J.  Montero,  and  Stefan  Glück. Center for  Translational  Therapeutics,  Karmanos  Cancer  Institute, Detroit,  MI,  USA.  Division  of  Hematology/  Oncology,  Sylvester  Comprehensive  Cancer  Center,  University  of  Miami, Leonard M. Miller School of Medicine, Miami, FL, USA. Biomark Cancer. 2013 Oct 29; 5:61-70. PMID: 24502342.
  2. Trastuzumab  emtanzine  (T-DM1)  in  the  treatment  of  HER -2  positive  breast  cancer. Muaiad Kittaneh and Patricia  LoRusso;  Expert  Opinion  Article;  Journal  of Symptoms and  signs 2013;  Volume 2, umber ; PP 213-221
  3. Exemestane  in  the  Adjuvant  Treatment  of  Breast  Cancer  in  Postmenopausal  Women. Muaiad Kittaneh and  Stefan  Glück;  Breast  Cancer:  Basic  and  Clinical  Research  2011:5  209–226  doi:  0.4137/BCBCR.S6234. PMID: 22084574


  1. Successful Use of Trastuzumab with Anthracycline -based Chemotherapy Followed by Trastuzumab Maintenance in Patients with Advanced HER2-positive Gastric Cancer. Palacio S, Loaiza -Bonilla A, Kittaneh M,Kyriakopoulos C ,Ochoa RE, Escobar M , Arango B , Restrepo MH, Merchan JR, Lima   CM, Hosein PJ . Anticancer Res. 2014 Jan;34(1):301-6. PMID:24403478
  2. 2 – F - 18 FDG PET/CT in the Assessment of Recurrent Anaplastic TCell Lymphoma of  the  External  Auditory  Canal ; Gomaa,  Osama  MD;  Serafini,  Aldo  N.  MD;  Franzmann,  Elizabeth  MD; Kittaneh,Muaiad MD ; Montague, Naomi MD; Kalkanis, Dimitrios MD. Clin Nucl Med .August 2010 - Volume 35 - Issue 8 -pp 592 - 594. PMID: 20631507


  1. Adjuvant   Therapy   for Early Breast   Cancer.Current   Cancer  Treatment   Novel   Beyond Conventional Approaches.InTech Open Access Publication.ISBN 978-953-307-397-2PP. 333-352. Published 12/2011


  1. The  Peter  Cassileth,  M.D  Award.  University  of  Miami  award  to  a  Hematology -Oncology fellow who  has  demonstrated  outstanding  clinical  judgment,  enthusiasm  for  learning,  and  compassionate care. June 2012.
  2. Conquer Cancer Foundation of ASCO 2011 Oncology Trainee Award, May 2011.
  3. Chief  Medical Resident Award. In recognition of outstanding contribution to the internal medicine residency program University of Illinois at Chicago, Advocate Christ medical center. 2008-2009.
  4. National ACP Merit Award in recognition of associates vignette poster competition winner,Internal Medicine, Washington, DC. 2008
  5. Teaching excellence award, University of Illinois at Chicago,Advocate Christ medical center. June 2008.
  6. John O’Brien award for excellence in clinical medicine,University of Illinois at Chicago,Advocate  Christ Medical Center, June 2008.
  7. Award  for  the  best  Clinical  Vignette  Presentation  at  the  Clinical  Vignette  and  Research  Fair  at Advocate Christ Medical Center,Oak Lawn,Illinois,2007.
  8. Undergraduate research awardfrom Howard Hughes MedicalInstitute EducationInitiative,IowaState University,Ames, Iowa,1998.

end faq

My Roots At Al-Quds university


I am deeply connected to my roots at Al-Quds. This is the place where I first grew as a medical student. I consider myself a lucky person to have been one of the first group of graduates of Al-Quds university medical school. Training at Al-Quds had contributed the most to my career success. 

It is more than just a place where I studied medicine. It is not by the number of years spent there. It is a school where I learned many skills that gave me the power to a successful life and career. I admired my Al-Quds teachers and colleague who had a significant impact on my career choices. I learned to fight for justice and pursue dreams where everyone else thought they are impossible. 

I did accomplish a lot in the last 13 years but I still strive for more opportunities and challenges in career and life.

Dr. Muaiad Kittaneh, MD, Medical School '2001

FACP, Assistant Professor of Medicine

Wayne state University- Detroit, MI, USA